Fermenta Biotech Limited (BOM:506414)

India · Delayed Price · Currency is INR

458.25

+8.85 (1.97%)

At close: Aug 17, 2026

27.40% (1Y)

Market Cap	13.14B +24.3%
Revenue (ttm)	5.11B -3.2%
Net Income	596.69M -42.9%
EPS	20.39 -43.0%
Shares Out	28.67M
PE Ratio	22.47
Forward PE	n/a
Dividend	3.75 (0.83%)
Ex-Dividend Date	Aug 5, 2026

Volume	26,038
Open	451.00
Previous Close	449.40
Day's Range	437.60 - 460.50
52-Week Range	256.40 - 579.65
Beta	-0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup... [Read more]

Industry Pharmaceutical Preparations

Founded 1951

Employees 630

Stock Exchange Bombay Stock Exchange

Ticker Symbol 506414

Full Company Profile

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.25 billion, an increase of 11.92% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.

Financial Statements